| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.76▼ | 6.74▼ | 6.74▼ | 6.66▲ | 6.41▲ |
| MA10 | 6.84▼ | 6.75▼ | 6.71▼ | 6.62▲ | 6.18▲ |
| MA20 | 6.71▼ | 6.59▲ | 6.57▲ | 6.33▲ | 6.10▲ |
| MA50 | 6.44▲ | 6.27▲ | 6.26▲ | 6.16▲ | 6.44▲ |
| MA100 | 6.17▲ | 6.06▲ | 6.06▲ | 6.09▲ | N/A |
| MA200 | 6.42▲ | 6.19▲ | 6.04▲ | 5.96▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.041▼ | -0.019▼ | -0.013▼ | 0.033▲ | N/A |
| RSI | 49.651▼ | 53.129▲ | 53.800▲ | 58.966▲ | N/A |
| STOCH | 44.485 | 54.885 | 56.061 | 65.129 | 71.397 |
| WILL %R | -76.596▼ | -70.588 | -61.017 | -30.894 | -20.652▲ |
| CCI | -77.418 | -20.433 | -4.845 | 79.839 | 170.743▲ |
|
Monday, January 04, 2021 03:30 AM
BiomX Inc. (NYSE:PHGE), a clinical stage company developing natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that Jonathan ...
|
|
Thursday, December 10, 2020 07:10 AM
BiomX Inc. (NYSE: PHGE) rose 11.2% to $6.65 in pre-market trading as the company announced presentation of preclinical results of analysis of patient samples and engineering of phage for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/01/21 | 6.61 | 6.80 | 6.61 | 6.71 | 9,100 |
| 14/01/21 | 6.46 | 6.69 | 6.46 | 6.69 | 29,500 |
| 13/01/21 | 6.50 | 6.56 | 6.45 | 6.56 | 15,700 |
| 12/01/21 | 6.61 | 6.83 | 6.53 | 6.57 | 97,000 |
| 11/01/21 | 6.77 | 6.82 | 6.53 | 6.77 | 24,274 |
| 08/01/21 | 6.64 | 7.09 | 6.64 | 6.97 | 78,700 |
| 07/01/21 | 6.45 | 6.64 | 6.34 | 6.64 | 36,200 |
| 06/01/21 | 6.30 | 6.60 | 6.30 | 6.57 | 19,100 |
| 05/01/21 | 6.15 | 6.43 | 6.08 | 6.43 | 43,690 |
| 04/01/21 | 6.0571 | 6.38 | 6.01 | 6.31 | 81,061 |
|
|
||||
|
|
||||
|
|